Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 2.95 -1.67% -0.05
ACHN closed down 1.67 percent on Thursday, February 22, 2018, on 1.16 times normal volume. It was able to find support at its 50 day moving average.
7 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Feb 22 50 DMA Support Bullish 0.00%
Feb 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 22 Wide Range Bar Range Expansion 0.00%
Feb 22 Doji - Bullish? Reversal 0.00%
Feb 22 Wide Bands Range Expansion 0.00%
Feb 22 Down 3 Days in a Row Weakness 0.00%
Feb 21 Wide Bands Range Expansion -1.67%
Feb 20 Wide Bands Range Expansion -1.99%
Feb 20 Overbought Stochastic Strength -1.99%
Feb 20 Upper Bollinger Band Touch Strength -1.99%

Older signals for ACHN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company's drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.66
52 Week Low 2.58
Average Volume 2,475,976
200-Day Moving Average 3.8842
50-Day Moving Average 2.9217
20-Day Moving Average 2.8825
10-Day Moving Average 2.991
Average True Range 0.1665
ADX 24.95
+DI 14.96
-DI 25.64
Chandelier Exit (Long, 3 ATRs ) 2.7405
Chandelier Exit (Short, 3 ATRs ) 3.0795
Upper Bollinger Band 3.1633
Lower Bollinger Band 2.6017
Percent B (%b) 0.62
BandWidth 19.483088
MACD Line 0.0254
MACD Signal Line 0.0019
MACD Histogram 0.0235
Fundamentals Value
Market Cap 403.44 Million
Num Shares 137 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -5.90
Price-to-Sales 33.83
Price-to-Book 1.40
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.46
Resistance 3 (R3) 3.43 3.24 3.38
Resistance 2 (R2) 3.24 3.11 3.25 3.35
Resistance 1 (R1) 3.09 3.03 3.17 3.12 3.32
Pivot Point 2.90 2.90 2.93 2.91 2.90
Support 1 (S1) 2.75 2.77 2.83 2.78 2.58
Support 2 (S2) 2.56 2.69 2.57 2.55
Support 3 (S3) 2.41 2.56 2.53
Support 4 (S4) 2.44